Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Selective, nonpeptide Y1 receptor antagonist reduces NPY-mediated food intake in rats

Nov. 2, 1998

HMR presents new agents for lipid disorders

Nov. 2, 1998

Licensing opportunity from the NIH: technology for enhancing embryo implantation

Nov. 2, 1998

BioStratum's Pyridorin effective for diabetic nephropathy

Oct. 30, 1998

Oral insulin formulation developed at Generex headed for U.S. clinical trials

Oct. 30, 1998

Novel vitamin D compounds claimed for use in bone disorders and psoriasis

Oct. 30, 1998

Thiocarbamic acid derivatives as inhibitors of squalene epoxidase

Oct. 29, 1998

Novel class of vitamin D derivatives for metabolic bone diseases, psoriasis

Oct. 29, 1998

Antiprogestin with potential as an oral postcoital contraceptive in women

Oct. 29, 1998

AERx Diabetes Management System enters phase II trials

Oct. 29, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...